Clinical trials offer hope in the fight against cancer !http://www.mlive.com/health/index.ssf/2010/11
Sue Schroder is a member of Grand Rapids Clinical Oncology Program's Patient Advisory Board and free-lance writer and editor. Her weekly "Living with Cancer" column appears in The Grand Rapids Press and its online affiliate, Mlive.com. Through patient stories, hers and others, she explores the uncharted territory of living with cancer. For a complete listing of Sue's articles, visit:
http://connect.mlive.com/user/sschroder/index.html
STAR: Study of Tamoxifen And Raloxifene: The Study of Tamoxifen and Raloxifene (STAR), was the largest North American breast cancer prevention trial ever undertaken and reached it's goal of enrolling 19,000 women to the trial in June, 2004. Grand Rapids Clinical Oncology Program enrolled 226 women!
To take your breast cancer assessment online: BreastCancerPrevention.com.
SELECT: Selenium and Vitamin E Cancer Prevention Trial: SELECT closed in June, 2004 enrolling 35,534 men. Grand Rapids Clinical Oncology Program enrolled 356 men.
Sheryl M. Ness, Mayo Clinic nurse educator, discusses clinical trials, what they are and how they work, on her blog.
Cure Magazine examines “The Treatment Option You May be Missing” in an extensive look at clinical trials in its summer issue.
Copyright 2010. Grand Rapids Clinical Oncology Program. All rights reserved.